Biofarm (LTS:0HTH) Inventories, Raw Materials & Components: lei35.5 Mil (As of Mar. 2026)


LTS:0HTH Biofarm SA LTS:0HTH
69 GF Score
Price lei0.24
GF Value lei0.15
! 6 Warning Signs
View Full Analysis

What is Biofarm Inventories, Raw Materials & Components?

Biofarm LTS:0HTH 69 Inventories, Raw Materials & Components is lei35.5 Mil as of Mar. 2026. GuruFocus rates LTS:0HTH with a GF Score™ of 69/100 and a GF Value™ of lei0.15. The stock has 6 warning signs investors should review.

Biofarm's inventories, raw materials & components for the quarter that ended in Mar. 2026 was lei35.5 Mil.

Biofarm's quarterly raw materials increased from Sep. 2025 (lei24.6 Mil) to Dec. 2025 (lei37.9 Mil) but then declined from Dec. 2025 (lei37.9 Mil) to Mar. 2026 (lei35.5 Mil).

Biofarm's annual raw materials declined from Dec. 2023 (lei39.1 Mil) to Dec. 2024 (lei31.4 Mil) but then increased from Dec. 2024 (lei31.4 Mil) to Dec. 2025 (lei37.9 Mil).

Biofarm Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Biofarm's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biofarm Inventories, Raw Materials & Components Chart

Biofarm Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.53 38.39 39.14 31.43 37.89

Biofarm Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.42 25.79 24.59 37.89 35.51
LTS:0HTH
69GF Score
Biofarm SA LTS:0HTH
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biofarm Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of lei35.5 Mil mean?
Biofarm (LTS:0HTH) has a Inventories, Raw Materials & Components of lei35.5 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Biofarm and its competitors.
Is Biofarm's Inventories, Raw Materials & Components too high?
Biofarm's current Inventories, Raw Materials & Components is lei35.5 Mil. Overall, Biofarm has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does Biofarm's Inventories, Raw Materials & Components compare to ZTS and UTHR?
Biofarm's Inventories, Raw Materials & Components of lei35.5 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Drug Manufacturers company?
A good Inventories, Raw Materials & Components depends on the Drug Manufacturers industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Biofarm and its competitors. Biofarm's current Inventories, Raw Materials & Components is lei35.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biofarm stock overvalued right now?
Biofarm (LTS:0HTH) has a current Inventories, Raw Materials & Components of lei35.5 Mil. The stock's GF Value™ is lei0.15, compared to a current price of lei0.24 — trading 58% above its estimated fair value. The current Inventories, Raw Materials & Components is lei35.5 Mil. Biofarm's overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Biofarm (LTS:0HTH), the current Inventories, Raw Materials & Components is lei35.5 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biofarm (LTS:0HTH) Overvalued in 2026?

Based on GuruFocus' analysis, Biofarm stock appears to be overvalued. The current stock price of lei0.24 is trading 58% above its estimated GF Value™ of lei0.15.

Key valuation signals for LTS:0HTH:

  • Inventories, Raw Materials & Components: lei35.5 Mil
  • GF Value™: lei0.15 vs. price of lei0.24 (58% above fair value)
  • GF Score™: 69/100 with 6 warning signs

No single metric tells the full story. See the LTS:0HTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biofarm Business Description

Other Exchanges BIO:Romania
Address 99 Logofatul Tautu Street, Sector 3, Bucharest, ROU, 031212
Biofarm SA is a company engaged in production and marketing in the pharmaceutical sector. It is involved in the manufacture and wholesale of over-the-counter drugs, prescription medications, and dietary supplements. The firm's product portfolio includes pharmaceutical preparations for the digestive system, musculoskeletal system, immune stimulation, respiratory system, cold & flu symptoms, and venous circulation improvement, as well as multivitamins, antioxidants, antiseptics, disinfectants, and cosmetics, among others. Some of its brands are Triferment, Colebil, Cavit, Anghirol, Clorocalcin, and Bixtonim. Additionally, the company offers services, such as investment in research, promotion, and packaging.
69GF Score

Get the complete analysis for LTS:0HTH

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

lei0.24
Price
lei0.15
GF Value